[Abstract Only] Randomized Trial: Early Combination Therapy Provides Greater and Durable Long-term Glucose Control in Patients with Newly Diagnosed Type 2 Diabetes

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial – The Lancet (link to abstract – $ for full-text)

Commentaries: Two-drug combo more effective at lowering blood sugar in diabetes patients – UPI (free) AND New study shows long-term durability of early combination therapy in patients newly diagnosed with type 2 diabetes – MedicalXpress (free)